Last reviewed · How we verify
GoodSense Eye Drops Advanced Relief Moisturizer (DEXTRAN)
At a glance
| Generic name | DEXTRAN |
|---|---|
| Sponsor | Allergan |
| Drug class | Plasma Volume Expander [EPC] |
| Modality | Oligosaccharide |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
| First approval | 1978 |
Approved indications
- redness of the eye due to minor eye irritations
- further irritation
- dryness of the eye
Common side effects
Key clinical trials
- Repurposing Tilmanocept for Cardiac Sarcoidosis (PHASE2)
- PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy (PHASE2)
- A Phase 1 Study of PVT401 in Healthy Subjects (PHASE1)
- The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department (PHASE4)
- Neoadjuvant Immunotherapy ± Radiotherapy in MSI-H/dMMR Locally Advanced Colorectal Cancer (PHASE2)
- Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal) (NA)
- Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants (PHASE2)
- Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |